Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$26.91 - $47.15 $120,718 - $211,514
-4,486 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$32.97 - $56.85 $147,903 - $255,029
4,486 New
4,486 $207,000
Q2 2020

Aug 20, 2020

SELL
$29.93 - $50.1 $221,811 - $371,291
-7,411 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$30.35 - $67.14 $36,116 - $79,896
-1,190 Reduced 13.84%
7,411 $302,000
Q4 2019

Feb 14, 2020

BUY
$55.65 - $79.83 $11,686 - $16,764
210 Added 2.5%
8,601 $530,000
Q4 2018

Feb 14, 2019

BUY
$41.17 - $56.44 $58,049 - $79,580
1,410 Added 20.2%
8,391 $378,000
Q1 2018

May 15, 2018

SELL
$56.98 - $72.41 $12,193 - $15,495
-214 Reduced 2.97%
6,981 $406,000
Q4 2017

Feb 14, 2018

BUY
$53.3 - $74.56 $7,728 - $10,811
145 Added 2.06%
7,195 $464,000
Q3 2017

Nov 14, 2017

BUY
$43.46 - $52.49 $306,393 - $370,054
7,050
7,050 $370,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $986M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Diker Management LLC Portfolio

Follow Diker Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diker Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Diker Management LLC with notifications on news.